SLE is Not a One-size-fits-all Disease

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2023 Apr 25

PMID 37097613

Authors

Michael R Ehrenstein

Muhammad Shipa

Affiliations

Soon will be listed here.

Abstract

In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.

Citing Articles

Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases.

Wang Y, Wei W, Ouyang R, Chen R, Wang T, Yuan X Lupus Sci Med. 2024; 11(1).

PMID: 38302133 PMC: 10831448. DOI: 10.1136/lupus-2023-001125.

References

van Vollenhoven R . String of successful trials in SLE: have we cracked the code?. Lupus Sci Med. 2020; 7(1):e000380. PMC: 7008706. DOI: 10.1136/lupus-2019-000380. View

Falasinnu T, Chaichian Y, Bass M, Simard J . The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus. Curr Rheumatol Rep. 2018; 20(4):20. PMC: 5857270. DOI: 10.1007/s11926-018-0728-2. View

Sarsour K, Beckley-Kartey S, Melega S, Odueyungbo A, Kirchner P, Khalife N . Rituximab utilization for approved and off-label nononcology indications and patients' experiences with the Patient Alert Card. Pharmacol Res Perspect. 2020; 8(1):e00555. PMC: 6941895. DOI: 10.1002/prp2.555. View

Owen K, Grammer A, Lipsky P . Deconvoluting the heterogeneity of SLE: The contribution of ancestry. J Allergy Clin Immunol. 2021; 149(1):12-23. DOI: 10.1016/j.jaci.2021.11.005. View

Carter E, Barr S, Clarke A . The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016; 12(10):605-20. DOI: 10.1038/nrrheum.2016.137. View

Panousis N, Bertsias G, Ongen H, Gergianaki I, Tektonidou M, Trachana M . Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis. 2019; 78(8):1079-1089. PMC: 6691930. DOI: 10.1136/annrheumdis-2018-214379. View

Yen E, Singh R . Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015. Arthritis Rheumatol. 2018; 70(8):1251-1255. PMC: 6105528. DOI: 10.1002/art.40512. View

Morand E, Furie R . Anifrolumab in Systemic Lupus Erythematosus. Reply. N Engl J Med. 2020; 382(17):1666. DOI: 10.1056/NEJMc2002191. View

Northcott M, Gearing L, Bonin J, Koelmeyer R, Hoi A, Hertzog P . Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus. Front Immunol. 2022; 13:964263. PMC: 9430375. DOI: 10.3389/fimmu.2022.964263. View

10.

Li K, Wang Z . Non-coding RNAs: Key players in T cell exhaustion. Front Immunol. 2022; 13:959729. PMC: 9577297. DOI: 10.3389/fimmu.2022.959729. View

11.

Carter L, Isenberg D, Ehrenstein M . Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. Arthritis Rheum. 2013; 65(10):2672-9. DOI: 10.1002/art.38074. View

12.

Ehrenstein M, Mauri C . If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine. J Exp Med. 2007; 204(10):2249-52. PMC: 2118461. DOI: 10.1084/jem.20071737. View

13.

Figgett W, Monaghan K, Ng M, Alhamdoosh M, Maraskovsky E, Wilson N . Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus. Clin Transl Immunology. 2020; 8(12):e01093. PMC: 6946916. DOI: 10.1002/cti2.1093. View